Also known as Ranimustine
Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.
via PubMed
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).